Model Medicines' Oral Anti-COVID-19 Drug Candidate MDL-001 Found to Significantly Reduce Viral Load in Lungs; Accepted into NIH's Antiviral Program for Pandemics (APP)

Media coverage

• Title	Model Medicines' Oral Anti-COVID-19 Drug Candidate MDL-001 Found to Significantly Reduce Viral Load in Lungs; Accepted into NIH's Antiviral Program for Pandemics (APP)
  Media name/outlet	BioSpace
  Country/Territory	United States
  Date	8/02/22
  URL	https://www.biospace.com/article/releases/model-medicines-oral-anti-covid-19-drug-candidate-mdl-001-found-to-significantly-reduce-viral-load-in-lungs-accepted-into-nih-s-antiviral-program-for-pandemics-app-/?s=106
  Persons	Kris White, Adolfo Garcia-Sastre

• Title	Model Medicines' Oral Anti-COVID-19 Drug Candidate MDL-001 Found to Significantly Reduce Viral Load in Lungs; Accepted into NIH's Antiviral Program for Pandemics (APP)
  Media name/outlet	Pharma's Almanac
  Country/Territory	United Kingdom
  Date	8/02/22
  URL	https://www.pharmasalmanac.com/articles/model-medicines-oral-anti-covid-19-drug-candidate-mdl-001-found-to-significantly-reduce-viral-load-in-lungs-accepted-into-nihs-antiviral-program-for-pandemics-app
  Persons	Kris White, Adolfo Garcia-Sastre

• Title	Model Medicines Reports Positive Results for Anti-COVID-19 Drug Candidate
  Media name/outlet	Contract Pharma
  Country/Territory	United States
  Date	8/02/22
  URL	https://www.contractpharma.com/contents/view_breaking-news/2022-02-08/model-medicines-reports-positive-results-for-anti-covid-19-drug-candidate/
  Persons	Kris White, Adolfo Garcia-Sastre